Handbooks >Drug GMPMedical DeviceClinical - LaboratoryBiologic-Blood-TissueCosmetic-Food-DietaryElectronic SystemsEU - ICH - Misc.More...

Auditing and Validation Services for FDA Regulated Industry

Training conducted by GMP Auditors...
from the Auditor's Perspective!



P Aud


Tel: 001-856-596-2333 info@auditing.com

Notice 1: The US FDA issued a ‘Proposed Rule for Comment’ in the Federal Register on Friday, 8 September, 2017.

As Senior Editor of GMP Publications and GXP News, and the Senior Auditor for The Auditing Group, I had anticipated this Proposed Rule to surface with the new Administration.  http://www.gxpnews.com/170908-GXPNews.html.

As part of the implementation of Executive Order 13771 entitled, ``Reducing Regulation and Controlling Regulatory Costs,'' and Executive Order 13777 entitled, ``Enforcing the Regulatory Reform Agenda,'' the FDA is seeking comments and information from interested parties to help FDA identify existing regulations and related paperwork requirements that could be modified, repealed, or replaced, consistent with the law, to achieve meaningful burden reduction while allowing us to achieve our public health mission and fulfill statutory obligations.'

Relates to the products regulated by CDER, CBER, CDRH CFSAN, CVM, Tobacco and ORA.
Comments must be issued by December 7th, 2017.

As Editor of GXP News and GMP Publications, one of my daily responsibilities is to monitor all rule changes published by the FDA Centers. Only minor Title 21 CFR rule changes have been published within the last 8 months, inconsistent with the Executive Order to reduce regulations. So, we know this was coming.

In accordance with the FDC Act, all industries which are required to comply with the regulations outlined with the US Title 21 Code of Federal Regulations, must follow all of the requirements under Title 21 which are applicable based upon ‘Risk’ and ‘Applicability’.

We need to ensure is that all of the ‘Predicate Rules’ are maintained and not compromised, to protect the efficacy, safety, purity, validity and quality of all products which are subject to Title 21 requirements. 
Before rule changes are considered, to satisfy the Executive Orders, appropriate formal risk assessments must be conducted by qualified authorities and not just the Agency based upon just public comments.  Outside quality authorities, such as GMP Auditors, Quality SMEs, and Industry must have first review, and then, those proposed changes must be issued for public comment, prior to Final Rule execution.

Risk assessments must take into consideration the ‘direct’ and ‘in-direct’ applicability as well, in accordance with a formal risk based approach.  We should not ‘run’ to modified, repealed, or replaced the regulations without due-diligence approach to risk and applicability.



  >>  Auditing Services   >>  Remediation Services

GMP, GCP, GLP, QS and Part 11 / Systems Audits

21 CFR Part(s) 11, 210/211, 820, ICH Q7

Food and Supplement GMP Audits

Mock FDA - EMEA Audits

Pre-Site Inspections - 'For-Cause'

Quality Assurance Audits

Quality System Audits - Part 820

SOPs, Quality Assurance and Standards Audits

GMP - Good Manufacturing Practice Audit

GCP - Clinical Audits - Regulatory Audits

Equipment Validation Documentation Audit

Software / Systems Validation Audits

Part 11 / Annex 11 Compliance

Vendor & Supplier Audits -

CMOs, Laboratories, API Manufacturers

CROs, Investigators, Monitors, and Study Sites

Database Audits, SAS, CMMS, eDC, eCFR, Safety

Project Management and Support Services

Gantt and Timeline Development

Validation Development and Executions

Training Services

Template Implementation

Procedures and Practice Challenges

Standard Operating Procedures Development

Development Part 11 Initiatives

Design / Build Engineering Services

Certified AIA 'As-Built' Drafting Services

Process and Equipment Validation Services

Software and Systems Validation Services

Design / Build Engineering Services


New GMP Basic Training Courses
$2,495.00 All Inclusive!

Looking for a
'Turn-Key' GMP Compliance Solution?

GMP Publications

GXP News for the Regulated Industry Whats new with the FDAGXP Academy
GXP Recruiters - Recruiters for the BioPharmaceutical Industry

2002 - 2015 The Auditing Group, Inc., a New Jersey Corporation. All rights reserved
Home  |  Contact Us  |  Site Map

Auditing - Full Service Auditing Services